News
FTC Aims Manufacturer, PBM Rebates For Rising Insulin Costs
Bribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US regulators, with a particular focus on rising insulin prices. The Federal Trade Commission (FTC) announced recently that it would step up enforcement against practises...
News
Keeping The Risk of Packaging In Check With Kids Involved
In the pharmaceutical industry and other consumer markets that produce and sell hazardous substances, child-resistant packaging has become an essential element of packaging design. As legislation and regulations increase all around the world and more firms take the moral pledge...
News
5-Year Kymriah Data Shows Long-Term Life In Kids And Teens
Novartis’ Kymriah created history five years ago when it became the first gene therapy to be licenced in the United States. As Novartis has attempted to increase its use in the lymphoma arena, the therapy has had its highs and...
News
FDA Staff Recommends Moderna, Pfizer COVID-19 Jabs For Kids
Parents may soon be allowed to line up their children for vaccinations after Pfizer and Moderna's COVID-19 vaccine application for young children progresses through the FDA's regulatory procedure. Independent experts will vote this week as to whether to recommend...
News
FDA Says It Must Assess Novavax COVID-19 Production Changes
The US handed Novavax a $1.6 billion funding 4 months into the pandemic, in July 2020, to speed the biotech's research of a coronavirus vaccine. The United States is still waiting for a return on its investment—and the 110...
News
FDA Rebukes Althera For Its Cholesterol Medication Claims
Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its cholesterol oral delivery medicine, Roszet. The FDA's Office of Prescription Medication Promotion is watching the drug, which combines two common cholesterol therapies into one...
News
The North Carolina Seqirus Factory Gets A $156mn Upgrade
Seqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish production plant, which began in 2018. The expanded facility, along with the recent FDA approval of its new prefilled syringe line, puts Seqirus in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read